Acetyl-11-keto-β-boswellic acid attenuates tau oligomer-induced neurotoxicity in neuroblastoma cell model
Authors:
Open Access
- 12 February 2026
- journal article
- research article
- Published by Springer Nature in BMC Neuroscience
- Vol. 27 (1)
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by microtubule destabilization, neuroinflammation, and tau patholoKeywords
This publication has 42 references indexed in Scilit:
- Molecular Therapeutics in Development to Treat Alzheimer’s DiseaseMolecular Diagnosis & Therapy, 2024
- Exploring the Role of Tau Proteins in Alzheimer’s Disease from Typical Functioning MAPs to Aberrant Fibrillary Deposits in the Brain2023
- Boswellic acids (K‐Vie™) improves clinical cognitive scores and reduces systemic inflammation in patients with mild to moderate Alzheimer’s disease.Alzheimer's & Dementia, 2022
- Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory propertiesBiomedicine & Pharmacotherapy, 2021
- Alzheimer’s disease improved through the activity of mitochondrial chain complexes and their gene expression in rats by boswellic acidMetabolic Brain Disease, 2020
- Acetyl-11-keto-β-boswellic acid ameliorates cognitive deficits and reduces amyloid-β levels in APPswe/PS1dE9 mice through antioxidant and anti-inflammatory pathwaysFree Radical Biology and Medicine, 2020
- Synthesis of new analogs of AKBA and evaluation of their anti-inflammatory activitiesBioorganic & Medicinal Chemistry, 2017
- Enhanced Neuroprotection of Acetyl-11-Keto-β-Boswellic Acid (AKBA)-Loaded O-Carboxymethyl Chitosan Nanoparticles Through Antioxidant and Anti-Inflammatory PathwaysMolecular Neurobiology, 2015
- Posttreatment with 11-Keto-β-Boswellic Acid Ameliorates Cerebral Ischemia–Reperfusion Injury: Nrf2/HO-1 Pathway as a Potential MechanismMolecular Neurobiology, 2014
- An in vitro study of the role of β‐boswellic acid in the microtubule assembly dynamicsFEBS Letters, 2012